DJIA 16,912.11 -70.48 -0.42%
NASDAQ 4,442.70 -2.21 -0.05%
S&P 500 1,969.95 -8.96 -0.45%
market minute promo

GlaxoSmithKline (NYSE: GSK)



company name or ticker
Company Photos
(Click to zoom)

What Are Theravance's GSK Drugs Really Worth?

Novartis Division Gets European Approval for Simbrinza - Analyst Blog

Novartis Division Gets European Approval for Simbrinza - Analyst Blog

A Look at the Week's Top Dividend Growers

What Makes Johnson & Johnson a Healthy Dividend Investment

Reckitt Benckiser leads U.K.’s FTSE 100 to small gain

Reckitt Benckiser leads U.K.’s FTSE 100 to small gain

Why GlaxoSmithKline (GSK) Stock Is Higher Today

Top Analyst Upgrades and Downgrades: AcelRx, Cisco, CIT, Juniper, Pfizer, Xerox and Many More

Wall Street Breakfast: Tax Inversions, Solar Tariffs, Samsung Delay

GlaxoSmithKline Declines on Corruption Investigation as European ADRs Drop on Lower German Confidenc

GlaxoSmithKline Declines on Corruption Investigation as European ADRs Drop on Lower German Confidence Data

GlaxoSmithKline (GSK) Weak In Early Morning Trading

See More Articles...